Pfizer, Inc. vs Stryker Corporation — Stock Comparison
Pfizer, Inc. (PFE) and Stryker Corporation (SYK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Stryker Corporation scores ahead of Pfizer, Inc. on Q·Score (7.4 vs 6.4 out of 10), led by Sentiment (7.9 vs 5.3) and Quality (7.7 vs 6.4). Analyst consensus targets imply greater upside for SYK (+25.7%) than for PFE (+15.8%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Forward P/E of 8.9× is low relative to sector peers.
⚠ earnings contracting 10% year-over-year.
Consensus analyst target of $386.80 is 26% above current price.
Analyst Consensus
Fundamentals
Frequently Asked Questions
PFE vs SYK: which stock scores better overall?
Based on Q·Score, Stryker Corporation (SYK) scores 7.4/10 versus Pfizer, Inc. (PFE) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: PFE or SYK?
Stryker Corporation (SYK) scores higher on Growth (5.9/10 vs 5.1/10). Pfizer, Inc. reports revenue growth (5.4% YoY) while Stryker Corporation reports (2.6% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is PFE or SYK more attractively valued?
Stryker Corporation (SYK) scores higher on Valuation (8.2/10 vs 7.7/10). PFE trades at 8.9× P/E versus SYK at 18.4×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about PFE vs SYK?
There are 27 analysts covering PFE with a consensus price target of $29.19, and 25 analysts covering SYK with a consensus target of $386.80. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: PFE or SYK?
Stryker Corporation (SYK) scores higher on Quality (7.7/10 vs 6.4/10). Net profit margin: PFE at 11.8%, SYK at 13.2%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: PFE or SYK?
Stryker Corporation (SYK) scores higher on Financial Health (7.4/10 vs 7/10). Market beta: PFE at 0.29, SYK at 0.79. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of PFE and SYK?
Pfizer, Inc. (PFE) has a market capitalisation of $143.7B, while Stryker Corporation (SYK) has a market cap of $118.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do PFE or SYK pay dividends?
PFE pays a dividend yield of 6.61%, while SYK pays a dividend yield of 1.13%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →